Literature DB >> 3715400

Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa.

K Borch, H Renvall, G Liedberg, B N Andersen.   

Abstract

It has been suggested that gastrin may be a causative factor in the proliferation of gastric fundic mucosal endocrine cells, as seen in the Zollinger-Ellison syndrome and in atrophic gastritis with hypergastrinemia of antral origin. In the present study, morphometrically determined densities of endocrine cells in fundic mucosal biopsy specimens were related to basal levels of serum gastrin in 10 normal controls and 60 patients with achlorhydric fundic atrophic gastritis, of which 45 had pernicious anemia (5 with fundic mucosal carcinoid) and 15 had atrophic gastritis without pernicious anemia. The densities of fundic mucosal endocrine cells were positively related to the levels of serum gastrin (atrophic gastritis, rs = 0.65; atrophic gastritis and normal controls, rs = 0.72). The highest levels of serum gastrin were found in patients with carcinoid tumors (mean, 1659.3 pmol/l), followed by those in patients with focal hyperplasias (cluster formation) of endocrine cells (mean, 503.2 pmol/l) and those in patients without focal hyperplasias (mean, 304.4 pmol/l) (p = 0.03 and p = 0.04, respectively).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715400     DOI: 10.3109/00365528609003087

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  42 in total

1.  Smooth Muscle Cell Abnormalities Associated with Gastric ECL Cell Carcinoids.

Authors:  Cesare Bordi; Pietro Caruana; Tiziana D'Adda; Cinzia Azzoni
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 2.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

3.  Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach.

Authors:  Y Tielemans; J Axelson; F Sundler; G Willems; R Håkanson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 4.  The endoproteolytic maturation of progastrin and procholecystokinin.

Authors:  Jens F Rehfeld
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

5.  Gastric enterochromaffin-like (ECL) cells in hypergastrinaemic duodenal ulcer disease.

Authors:  M Coupe; H Rees; C J Springer; A E Bishop; J A Morris; J M Polak; J Calam
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

6.  Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

Authors:  S M Sjöblom; P Sipponen; S L Karonen; H J Järvinen
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

7.  Increased incidence of pancreatic neoplasia in pernicious anemia.

Authors:  K Borch; E Kullman; S Hallhagen; T Ledin; I Ihse
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

8.  Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.

Authors:  G Cadiot; T Lehy; P Ruszniewski; S Bonfils; M Mignon
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

9.  A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.

Authors:  Marc J Berna; Bruno Annibale; Massimo Marignani; Tu Vinh Luong; Vito Corleto; Andrea Pace; Tetsuhide Ito; David Liewehr; David J Venzon; Gianfranco Delle Fave; Cesare Bordi; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

10.  Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man.

Authors:  H Koop; M Frank; S Kuly; R Nold; R Eissele; G Rager; J Rüschoff; M Rothmund; R Arnold
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.